Hematology/Oncology and Stem Cell Therapy (HOSCT) (1658-3876) is an international, peer-reviewed, open access journal published by the by the King Faisal Specialist Hospital & Research Centre.
Hematology/Oncology and Stem Cell Therapy (HOSCT) provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors. The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles and special communications. It also offers a special section for clinically relevant images that provide an important educational value.
Current Issue: Volume 16, Issue 2 (2023)
Review Articles
Efficacy and safety of recombinant thrombomodulin for the prophylaxis of veno-occlusive complication in allogeneiccit hematopoietic stem cell transplantation: A systematic review and meta-analysis
Richi Kashyap, Faiz Anwer, Muhammad Areeb Iqbal, Farhan Khalid, Anam Khan, Muhammad Ashar Ali, Muhammad Yasir Anwar, Anamika Chaudhary, and Ali Jaan
Current status and future perspectives on the Internet of Things in oncology
Ibrahim N. Muhsen, Omar W. Rasheed, Eiad A. Habib, Rakan K. Alsaad, Mohannad K. Maghrabi, Md A. Rahman, Douglas Sicker, William A. Wood, Muhammad S. Beg, Anthony D. Sung, and Shahrukh K. Hashmi
Research Articles
Diagnosis and treatment of subcutaneous panniculitis-like T-cell lymphoma: A systematic literature review
Dunya Yunus Alsomali, Nasir Bakshi, Mohamed Kharfan-Dabaja, Riad El Fakih, and Mahmoud Aljurf
Cross fire: Daratumumab-based therapies are standard of care in newly diagnosed multiple myeloma
Neha Korde and Saad Z. Usmani
Changes in heme levels during acute vaso-occlusive crisis in sickle cell anemia
Evilazio Cunha Cardoso, Pedro Vieira Silva-Neto, Bidossessi Wilfried Hounkpe, Francine Chenou, Cintia Cristina Mateus Xerez Albuquerque, Nadja Pinto Garcia, Alexander Leonardo Silva-Junior, Adriana Malheiro, Purim Cesar, Franciele de Lima, Erich V. De Paula, and Nelson Abrahim Fraiji
Predictors and management of relapse to Axicabtagene Ciloleucel in patients with aggressive B-cell lymphoma
Jose Vicente Forero-Forero, Paula A. Lengerke-Diaz, Eider Moreno-Cortes, Megan Melody, Zaid Abdel Rahman, Allison C. Rosenthal, Mohamed A. Kharfan-Dabaja, and Januario E. Castro
Original Research Report
Immune checkpoint inhibitor-induced pneumonitis: Incidence, clinical characteristics, and outcomes
Harsha Banavasi, Seongho Kim, Samer Alkassis, Asil Daoud, Amir Laktineh, Misako Nagasaka, Ammar Sukari, and Ayman O. Soubani
Case Report
Promising effect of PDL1 inhibitors in the front-line management of primary aggressive central nervous system lymphoma: A case report
Rasha El-Tawab, Abdulaziz Hamada, Rehab Elhagracy, Karen Pinto, and Salem Alshemmari
Letters to the Editor
Impact of pre-transplant induction therapy on outcomes of patients who undergo autologous stem cell transplantation for mantle cell lymphoma in first complete remission
Omar Albanyan, Samer Alkassis, Seongho Kim, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Dipenkumar Modi, Joseph P. Uberti, and Abhinav Deol
Predicting if lung cancer will relapse—The role of neutrophil/lymphocyte ratio
Abigail Chan, Søren Bentzen, Amit Rout, and Kenneth Miller
